Therefore, the PD-L1/PD-1 signalling axis is important for maintaining immune balance, and identifying effective therapeutic drugs targeting the PD-L1/PD-1 signalling axis may be the main research field for the clinical treatment of RA in the future. Here, PDCD1 is linked to rheumatoid arthritis.